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Abstract:  
The enteric pathogen, Salmonella enterica serovar Typhimurium, causes food poisoning 
resulting in gastroenteritis. The S. Typhimurium effector protein, SipA, promotes gastroenteritis 
by functional motifs that either trigger mechanisms of inflammation or bacterial entry. During 
infection of intestinal epithelial cells, SipA was found to be responsible for the early activation of 
caspase-3, an enzyme that is required for SipA cleavage at a specific recognition motif that 
divided the protein into its two functional domains, and activated SipA in a manner necessary for 
pathogenicity. Other caspase-3 cleavage sites identified in S. Typhimurium appeared to be 
restricted to secreted effector proteins, indicating this may be a general strategy employed by this 
pathogen for processing of its secreted effectors. 
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 Salmonella enterica serovar Typhimurium acquires virulence via a 40-kb segment of the 
bacterial chromosome designated Salmonella Pathogenicity Island 1 (SPI-1) (1). SPI-1 contains 
more than 25 genes encoding structural components and substrates of a type III protein-secretion 
system that mediates the translocation of effector proteins from Salmonella into mammalian cells 
(1). One of these, Salmonella invasion protein A (SipA), is a bifunctional molecule responsible 
for promoting actin polymerization, a process that facilitates bacterial entry into epithelial cells 
(2), and is required to trigger signal transduction cascades that promote polymorphonuclear 
leukocyte (PMN) migration across the intestinal epithelium (3). The actin binding function of 
SipA is known to be localized to a C-terminal fragment (amino acids 426−684), termed SipAb 
(4). We have reported that the N-terminal fragment of the SipA effector protein (amino acids 2-
425), harbors the functional domain that induces PMN transepithelial migration (5), which 
underlies the clinical manifestations of salmonellosis.  
 We discovered a caspase-3 motif, Asp-Glu-Val-Asp (DEVD), at amino acid position 
431-434 (Fig. 1A) of SipA at the junction between the two functional domains. Treatment of a 
purified fraction of SipA to activated caspase-3 enzyme generated a predicted fragment (55 kDa; 
Fig. 1B) and confirmed that the SipA DEVD cleavage motif was functionally active. The 
expected lower molecular weight band was not seen most likely due to lack of antibody 
recognition; however, mutation of the caspase-3 site by changing aspartic acid at position four to 
alanine (A) (DEVD DEVA; termed caspase site mutant: csm-SipA) rendered SipA insensitive 
to caspase-3 cleavage (Fig. 1B).  
 Although caspase-3 is a frequently activated death protease, this enzyme also catalyzes 
specific cleavage of many cellular proteins (6), and promotes cell proliferation and inflammation 
without inducing apoptosis (7). We found that S. Typhimurium infection of model intestinal 
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epithelia induced the activated form of the caspase-3 enzyme within 2 hour and persisted for at 
least 4 hour (Fig. 1C and Fig. S1A and B). Apoptosis occurred 24 hours following infection of 
epithelial cells (8). No activation of other initiator cysteine proteases known to play essential 
roles in apoptosis (i.e., caspase-1 or caspase-8) (Fig. 1C) was observed. Staurosporine treatment, 
which induces apoptosis and was used as a positive control, showed significant Annexin V 
staining, whereas the S. Typhimurium treated T84 cells showed minimal Annexin V binding and 
no propidium iodide staining (Fig. 1D), confirming that early after infection this pathogen can 
activate caspase-3 without inducing apoptosis or necrosis.  
A plasmid bearing the mutant clone, pCSM-SipA (for plasmid caspase site mutant), was 
transformed into both Escherichia coli F-18, an intestinal commensal isolate (9), and Salmonella. 
Since E. coli F-18 secretes SipA through the flagella basal body (5), we used this strain to assess 
the ability of the caspase-3 site mutant to drive PMN transepithelial migration in the absence of 
other S. Typhimurium virulence determinants. Using our in vitro inflammatory model system 
(10), we found that the mutant had a reduced capacity to induce PMN transepithelial migration 
(>95%; P<0.01) compared with the E. coli F-18 strain expressing the wild-type SipA protein 
(pSipA) (Fig. 1E).  
 Salmonella enterica serovar Dublin was used in the in vivo enteritis model because this 
strain constitutively expresses proteins from the pBH plasmid and allows the expression of 
proteins of interest in animal infections (5,11, 12). Macroscopic inspection of the intestines 
revealed inflammation of the cecum in infections with both wild-type Salmonella and the ∆SipA 
mutant strain expressing SipA (∆SipA/pSipA) (Fig. 2A). By contrast, no overt signs of intestinal 
inflammation were observed in mice infected with the ∆SipA mutant strain expressing the 
caspase-3 site mutant (∆SipA/pCSM-SipA), the ∆SipA mutant strain, or the buffer negative 
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control (Fig. 2A). Histological evaluation of hematoxylin and eosin (H&E) stained tissue 
sections and the pathology scores for disease severity showed significant inflammation of the 
proximal colons of mice infected with either wild-type Salmonella or ∆SipA/pSipA, as 
determined by colonic wall thickening, crypt elongation, PMN infiltration, epithelial erosion, and 
edema (Fig. 2A and 2C). By contrast, infections with both the ∆SipA/pCSM-SipA and ∆SipA 
mutant strains did not cause pronounced intestinal inflammation (Fig. 2A and 2C). 
Quantification of infiltrating PMNs, as determined by myeloperoxidase (MPO) activity, 
supported these observations (Fig. S2). 
 Cleavage of the SipA DEVD recognition site appears to be important for promoting 
proinflammatory responses and suggests a role for caspase-3. Consistent with this notion, 
Salmonella is less virulent in caspase-3 knockout (caspase-3-/-) mice, as judged by gross cecal 
and histopathologic examination of the proximal colons of Salmonella-infected caspase-3-/- mice, 
which reveals significantly less intestinal pathology compared to Salmonella-infected wild-type 
mice (Fig. 2B and 2D). In addition, reduced S. Typhimurium invasiveness in bone-marrow-
derived macrophages from caspase-3-/- mice, compared with wild-type macrophages further 
indicates that a lack of caspase-3 has an impact on the infection outcome (Fig. S2C).  Likewise, 
in vitro inhibition of epithelial derived caspase-3 by siRNA significantly reduced S. 
Typhimurium-induced PMN transepithelial migration (Fig. 2E), as did pharmacologic inhibition 
of caspase-3 (Fig. S3). 
 Remarkably, the SipA effector itself stimulated activation of caspase-3, whereas the 
∆SipA mutant strain was not able to (Fig. 3A and 3B), indicating that the effector is necessary 
and sufficient to promote activation of caspase-3. Moreover, S. Typhimurium non-polar, isogenic 
mutant strains defective in SipA expression and secretion (∆SPI-1 and ∆InvG, respectively), or 
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lacking transcription factors controlling SipA expression (∆HilA) also failed to induce caspase-3 
activation (Fig. 3C). Mutations in genes encoding other effector proteins not associated with 
SipA expression, such as avrA, did not adversely affect the expression of activated caspase-3 
(Fig. 3C). Levels of caspase-3 expression measured during S. Typhimurium infection of 
epithelial cells by quantitative PCR showed no new procaspase-3 was being produced (Fig. S4). 
However, activated caspase-3 does appear in the membrane insoluble fraction (Fig. 2D), 
suggesting that S. Typhimurium infection modifies existing pools of caspase-3.   
 In the intestinal lumen several environmental cues trigger the upregulation of the 
Salmonella SPI-1 type III secretion system (i.e., osmolarity, oxygen tension) (13, 14). Therefore, 
upon colonization, it is likely that Salmonella has begun to secrete effector proteins into the 
intestinal milieu. Although SipA is a type III secreted protein it is unique in its ability to act 
extracellularly and elicit a proinflammatory response (5). We hypothesized that processing of 
SipA by caspase-3 cleavage occurs at the apical epithelial surface, liberating the N-terminal SipA 
domain for its extracellular function, which presumably requires binding to a surface receptor 
(3). This offers an explanation of why the N-terminal domain, when expressed independently of 
the C-terminal domain, is a more potent inflammatory stimulus than the full-length protein (5).  
 In support of this hypothesis, S. Typhimurium infection of polarized T84 monolayers 
resulted in the preferential secretion of activated caspase-3, in a SipA dependent manner, into the 
apical epithelial compartment, but not the basolateral compartment (Fig. 3D). SipA processing 
also occurs extracellularly at the apical surface, as SipA cleavage products were recovered within 
apical supernatants following S. Typhimurium infection, but were not observed within the 
epithelial cell (Fig. 3E). Colonic mucus extracts were analyzed following Salmonella-induced 
colitis for the functional activity of caspase-3 and caspase-1 (a non-specific control) (9). 
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Consistent with our in vitro findings, only caspase-3 activity could be isolated from colonic 
mucus infected with Salmonella bearing a functional SipA (Fig 3F), and Salmonella infected 
mice were only capable of cleaving SipA possessing an intact caspase-3 recognition motif (Fig. 
3G).  Because these data demonstrate a novel mode of caspase-3 action we attempted to model 
these interactions in vitro. Exogenous addition of the caspase-3 enzyme to S. Typhimurium 
infected T84 monolayers significantly and specifically enhanced PMN transepithelial migration 
(Fig. S5). While these results validate the concept that caspase-3 dependent processing plays an 
important role in bacterial-induced inflammation, the underlying molecular mechanism of how 
caspase-3 becomes activated remains to be defined. However, during infection, caspase-3 
secretion does not appear to correlate with cell lysis (Fig. S6). 
 A detailed analysis of S. Typhimurium SPI-1 proteins revealed the existence of caspase-3 
recognition and cleavage sites in other secreted S. Typhimurium effectors (i.e., AvrA, SopB, 
SifA, SipB and SopA), but not type III secretion system structural proteins, chaperones or 
transcriptional regulators (Table 1). Like SipA, many of the caspase-3 cleavage sites in these 
other effector proteins are centrally located within the protein sequence, dividing the effectors 
into what, at least in the case of SifA, have been identified as two functional domains (15).  
These observations are further supported by studies with the effector protein, SopA, a HECT-like 
E3 ubiquitin ligase, which is also involved in inducing transepithelial migration of PMNs (16, 
17). SopA harbors two caspase-3 recognition motifs (449-463 and 478-492) that not only are 
positioned close to each other (Fig. 4A), but also are located in an exposed domain of the 
effector molecule (Fig. 4B). These SopA caspase-3 cleavage sites are functional, as exposure of 
SopA to the activated caspase-3 enzyme led to nearly complete digestion of the effector (Fig. 
4C). By contrast, single amino acid substitution at position four of the caspase-3 recognition site 
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to a motif not recognized by the enzyme (aspartic acid (D) to alanine (A): DSFD to DSFA and 
DCTD to DCTA), was refractory to capase-3 digestion (Fig. 4C). The inability to visualize the 
digested fragments is most likely due to instability of the resulting fragments or poor antibody 
recognition. Nonetheless, the SopA caspase-3 site double mutant had significantly less capacity 
to induce PMN transepithelial migration than the S. Typhimurium wild-type strain (> 50%; P < 
0.01).  
 Secreted effector proteins from other enteric pathogens, such as Shigella flexneri and 
Enteropathogenic Escherichia coli (EPEC), also harbor potential caspase-3 recognition sites 
(Tables S1 and S2). While some protein sequences were found to contain multiple caspase-3 
cleavage sites (i.e., IpaA and EspC), other sequences such as EPEC EspB protein, which is 
involved in the translocation of effector proteins during EPEC infection (18), exhibit discrete 
localization of the caspase-3 sites, depending on whether the strain is isolated from humans or 
other mammals (rabbits or mice). Of potential significance, most of the proteins having a 
putative caspase-3 recognition and cleavage site exhibit a dual function, like SipA, with distinct 
activities of the N- or C-terminus of the protein (19-22). Future studies will determine whether 
these secreted effectors are also processed post-transcriptionally by caspase-3. 
Our work reveals that S. Typhimurium has evolved a mechanism to deliver effector 
proteins in a precursor form to the host cell where they are subsequently processed into 
independent functionally active domains. Alteration of the caspase-3 motif or modulation of 
caspase-3 expression attenuates the ability of S. Typhimurium to induce gastroenteritis. Many 
effector proteins secreted by bacteria share caspase-3 cleavage motifs, inviting speculation that 
caspase-3 processing may be a common host-pathogen interaction. The intestinal epithelium is a 
barrier against invading pathogens, and caspase-3 induction/release may have evolved as a rapid 
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innate immune response to pathogens, perhaps in an attempt to kill or disarm the intruder (i.e., 
defensins). However, some pathogens such as S. Typhimurium appear to be able to subvert such 
defenses.  
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Figure Legends: 
Fig. 1. The effector protein SipA harbors a functional caspase-3 cleavage site. (A) Primary 
amino acid sequence of SipA showing the caspase-3 cleavage site (highlighted in red) between 
the N-terminal (green) and C-terminal (blue) domains. (B) Immunoblot of SipA in the absence 
and presence of caspase-3. The full length 89 kDa SipA effector is cleaved resulting in the 55 
kDa truncated N-terminal domain being produced. The caspase site mutant SipA (csm-SipA) is 
not cleaved by caspase-3. (C) Whole cell extracts from T84 cells that were uninfected or infected 
with wild-type S. Typhimurium (WT) were probed with anti-caspase-3, -1, -8 and a GAPDH 
control showing equal loading of lanes. (D) Annexin V staining as a measurement of apoptosis in 
T84 cells 2 hours post infection with wild-type S. Typhimurium (WT). Staurosporine treatment 
served as the positive control for apoptosis. (*) P < 0.01. (E) Alteration of the SipA caspase-3 
motif rendered SipA resistant to cleavage and attenuated the ability of S. Typhimurium to induce 
neutrophil (PMN) movement. PMN migration induced by SipA (blue bars) was far greater than 
with the pCSM-SipA (red bars) and was of the same extent as the wild-type S. Typhimurium 
strain (WT). (*), P < 0.01; (NS) not significant.  
 
Fig. 2. Mutation of the caspase-3 cleavage site attenuates the ability of the SipA effector to 
promote inflammation in an in vivo mouse model. (A) Disease pathology following a 48 hr 
infection of mice with different strains of Salmonella. The left panel shows gross morphology of 
the cecum while the right panels shows the histopathology of the sections stained with 
hematoxylin and eosin (H&E). The magnification bar is 100 µM. The ∆SipA mutant strain was 
complemented with either SipA (pSipA) or caspase-site-mutant SipA (pCSM-SipA). Phosphate 
buffered saline (PBS) treatment was the negative control. (B) Disease pathology following a 48 
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hour infection of wild-type mice and caspase-3 knock out mice (both on C57Bl/6 background). 
The left panel shows the gross morphology of the cecum, and the H&E stained sections of the 
proximal colon are shown on the right. The magnification bar is 100 µM. WT refers to the wild-
type Salmonella strain used for infection, and buffer refers to the PBS treated negative control. 
(C) The colonic histopathology for the sections shown in part A were quantified using a disease 
severity index (scale 0-8), with “0” scored normal and a score of “8” showing the most 
significant level of disease pathology (n=5). Sections were scored blinded by a trained 
pathologist. Data represent ± SD. (*), P < 0.01; (**), P < 0.05; (NS) not significant. (D) The 
colonic histopathology for sections in part B was quantified using the same disease severity 
index (scale 0-8, n=5). Data represent ± SD. (**), P < 0.05. (E) Neutrophil (PMN) transepithelial 
migration following small interfering RNA (siRNA) knockdown of caspase-3 in HCT8 cells 
expressing siRNA against caspase-3 (black bars) or containing a vector control (open bars). Cells 
were infected with either wild-type S. Typhimurium (WT) or a ∆HilA isogenic negative mutant 
(vv341), which is incapable of inducing migration (*), P<0.05. Immunoblot shows knockdown 
of caspase-3 expression by siRNA directed against caspase-3, actin was used a loading control.    
 
Fig. 3. SipA causes activation of caspase-3 and its release at the apical surface of the epithelium. 
(A) Time course of caspase-3 activation during S. Typhimurium infection of T84 cell 
monolayers. Cells were infected with either wild-type S. Typhimurium (WT) or the ∆SipA 
mutant. Casp3 refers to pro-caspase-3 while A-Casp3 represents the activated form of the 
enzyme; Soluble and insoluble refers to the respective membrane fractions. (B) The ∆SipA 
mutant strain complemented with a vector expressing SipA (∆SipA/pSipA) rescued the ability to 
induce the activation of caspase-3 following a 2 hour infection. Buffer refers to the buffer 
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control. (C) Infection of T84 cells with different isogenic mutant strains of S. Typhimurium. 
Immunoblots were performed on cell extracts 3 hour post infection with anti-caspase-3 antibody. 
Casp3 refers to pro-caspase-3; A-Casp3 represents the activated form of the enzyme. (D) 
Activated caspase-3 was released at the apical but not basolateral surface during in vitro 
infection of T84 cells with wild-type S. Typhimurium (WT). No caspase-3 was detected in 
∆SipA mutant infected wells or in the buffer control, uninfected wells. (E) Cleaved SipA was 
detected in apical media but not in the cell cytosol following infection with the ∆SipA mutant 
complemented with SipA (∆SipA/pSipA).  The arrow shows the N-terminal fragment generated 
by cleavage. No SipA is detected in the SipA negative mutant infected cells. (F) Caspase-3 
(black bars) or caspase-1 (open bars) activity was measured in mucosal extracts post in vivo 
infection of wild-type mice. Infection was carried out with wild-type Salmonella (WT), a ∆SipA 
mutant, and ∆SipA complemented with either SipA (∆SipA/pSipA) or pCSM-SipA 
(∆SipA/pCSM-SipA). Buffer refers to the uninfected buffer control. (G) Immunoblots showing 
cleavage of SipA after addition of mucosal extract isolated from mice infected with various 
indicated strains. WT refers to wild-type Salmonella and ∆SipA is the ∆SipA strain 
complemented with either wild-type SipA (SipA/pSipA) or the pCSM-SipA (∆SipA/pCSM-
SipA). Buffer refers to the negative control.  
 
Fig. 4. Cleavage sites have been identified in numerous other S. Typhimurium effectors. (A) 
Functional caspase-3 cleavage sites in SipA, SopA, and putative caspase-3 cleavage sites in other 
S. Typhimurium effectors. (B) Three dimensional image of the wild-type SopA protein showing 
the position of the two caspase-3 cleavage sties that are surface exposed.  (C) Immunoblot 
showing cleavage of SopA with caspase-3 and the absence of cleavage in the SopA caspase site 
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double mutant. (D) Neutrophil (PMN) transepithelial migration induced in vitro by infection 
with wild-type S. Typhimurium and a SopA mutant strain (∆SopA). ∆SopA/pCSM-SopA and 
∆SopA/pSopA are the ∆SopA strain complemented with the caspase site mutant of SopA (csm-
SopA) and wild-type SopA respectively. (*) P < 0.01. Migration levels shown are presented as 
the percent of the wild-type S. Typhimurium strain. 
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Figure 2 
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Figure 3 
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Figure 4 
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